AstraZeneca will spend £650m to build a new factory for vaccines in Liverpool, and upgrade research labs at Cambridge. This comes almost a full year after the chief executive of
Drug Research3- Page
41Articles
The shares of US biotech Viking Therapeutics have more than doubled since trial results for its weight-loss drug beat existing treatments from Novo Nordisk & Eli Lilly. In a mid-stage
AstraZeneca announced on Monday that its top drug has shown promising results in treating early-stage lung cancer by slowing down the progression of the disease. The company announced that its
Mounjaro, a weight-loss drug that is available in an injectable pen in Great Britain in the near future for the treatment of diabetes and obesity will be made available by
According to data from the European Health Agency, more than one billion dollars of Pfizer Covid-19 antiviral medications procured by Pfizer in Europe were wasted because strict controls on who
Syntara's $10M capital raise is propelling its drug development strategy into a new era. In this exclusive interview, CEO Gary Phillips unveils the transformative steps taken by Syntara Ltd, from its rebranding efforts to the strategic deployment of funds.
AstraZeneca has acquired its first vaccine company for $1.1bn. This will allow the company to expand its vaccine and immunotherapy business, which it established during the Covid pandemic. The largest
Novo Nordisk wants to help more people get Wegovy jabs, including those who are currently unable to access them. Novo Nordisk, a maker of obesity drugs, said that it would
AstraZeneca has contested accusations that the Covid-19 vaccine was “defective”, after a vaccine patient sued for damages, claiming to have suffered a severe side-effect. The Anglo-Swedish pharmaceutical company, which developed
